Announcements Trials
Browse Landscape

Phase

Phase 2/3 1Phase 2 1

Status

Recruiting 54Active not recruiting 44Completed 15Not yet recruiting 9Withdrawn 2Terminated 2Suspended 2Enrolling by invitation 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 2

Conditions

Neoplasms 18Breast Neoplasms 16Leukemia, Myeloid, Acute 15Glioblastoma 13Colorectal Neoplasms 13Prostatic Neoplasms 12Neoplasm Metastasis 10Carcinoma, Non-Small-Cell Lung 10Pancreatic Neoplasms 9Lung Neoplasms 9Glioma 8Carcinoma, Hepatocellular 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Multiple Myeloma 7Head and Neck Neoplasms 7Carcinoma, Renal Cell 7Ovarian Neoplasms 6Myelodysplastic Syndromes 6Hematologic Neoplasms 6Triple Negative Breast Neoplasms 5Rectal Neoplasms 5Melanoma 5Uterine Cervical Neoplasms 4Sarcoma 4Colonic Neoplasms 4Brain Neoplasms 4Solid Tumor 3Small Cell Lung Carcinoma 3Recurrence 3Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3

Interventions

Magnetic Resonance Spectroscopy 2atezolizumab 1Radiotherapy 1Radiation 1Platinum 1Neck Dissection 1Cisplatin 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Suspended × Oropharyngeal Neoplasms × 1 year × Clear all
NCT05050162 2026-05-07

Comparing Cisplatin Every Three Weeks to Cisplatin Weekly When Combined With Radiation for Patients With Advanced Head and Neck Cancer

NRG Oncology

Phase 2/3 Suspended
1,714 enrolled
Head & Neck

Carcinoma, Oropharyngeal Neoplasms

NCT06254911 2026-01-27

Pre-operative Atezolizumab in Patients With Resectable, Human Papillomavirus Related Oropharyngeal Carcinoma

Emory University

Phase 2 Suspended
20 enrolled
Head & Neck

Oropharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡